Role of traditional chinese and western medicines that inhibit aldose reductase in the treatment of diabetic neuropathy

Xiaochun Liang; Saishan Guo

doi:10.1007/BF02973162

Your Location：

Home >

Browse articles >

Role of traditional chinese and western medicines that inhibit aldose reductase in the treatment of diabetic neuropathy

ReviewPaper | Updated：2021-08-27

- Role of traditional chinese and western medicines that inhibit aldose reductase in the treatment of diabetic neuropathy
- Role of traditional chinese and western medicines that inhibit aldose reductase in the treatment of diabetic neuropathy
- 中国结合医学杂志（英文版） 2000年6卷第1期页码：76-79
- Affiliations：
  
  Beijing Union Hospital, PUMC, Academy of Chinese Medical Sciences,Beijing
- Author bio：
- Funds：
- DOI：10.1007/BF02973162
  中图分类号：
- 纸质出版日期：2000，
Scan for full text
Liang, X., Guo, S. Role of traditional chinese and western medicines that inhibit aldose reductase in the treatment of diabetic neuropathy., CJIM 6, 76 (2000). https://doi.org/10.1007/BF02973162

Xiaochun Liang, Saishan Guo. Role of traditional chinese and western medicines that inhibit aldose reductase in the treatment of diabetic neuropathy[J]. Chinese Journal of Integrative Medicine, 2000,6(1):76-79.
Liang, X., Guo, S. Role of traditional chinese and western medicines that inhibit aldose reductase in the treatment of diabetic neuropathy., CJIM 6, 76 (2000). https://doi.org/10.1007/BF02973162 DOI：

Xiaochun Liang, Saishan Guo. Role of traditional chinese and western medicines that inhibit aldose reductase in the treatment of diabetic neuropathy[J]. Chinese Journal of Integrative Medicine, 2000,6(1):76-79. DOI： 10.1007/BF02973162.

摘要

Abstract

关键词

sorbitolDiabetic NeuropathyAldose ReductaseSilymarinBaicalin

Keywords

sorbitolDiabetic NeuropathyAldose ReductaseSilymarinBaicalin

references

Douglas A, Green SA, Lattmer AF, et al. Are disturbances of sorbitol, phosphoinositides and Na+-K+ -ATPase regulatory involved in pathogenesis of diabetic neuropathy? Diabetes 1988; 37:688–693.

Yue DK, Broodks B. The role of aldose reductase inhibitors in the treatment of diabetic peripheral neuropathy. Med J Aust 1993; 159:76–79.

Masson EA, Boulton AJM. Aldose reductase inhibitors in the treatment of diabetic neuropathy: a review of the rational and clinical evidence. Drugs 1990;39:190–202.

Greene Da. Lattimer SA. Altered sorbitol and myoinositol metabolism as the basis for defective protein kinase C and Na+ -K+ -ATPase regulation in diabetic neuropathy. Ann NY Acad Sci 1986; 488:334–340.

Whiting PH, Ross IS. Increase nerve polyol levels in experimental diabetes and their reversal by sorbinil. Br Exp Pathol 1988;69:697–699.

Hotta N, Kakuta H, Fukasawa M, et al. Effects of a fructose rich diet and the aldose redutase inhibitor, ONO-2235, on the development of diabetic neuropathy in streptozotocin- treated rats. Diabetologia 1985;28:176–180.

Zhang JQ, Zhou YP. Inhibition of part of Chinese materia medica and their ingredients on rats’ lens aldose reductase. J Chin Mat Med 1989; 14(9):45–47.

Aida Kaoru. Kampo drugs’ on rats lens aldose reductase and human erythrocyte sorbitol accumulation. Hormone and Clinics 1985;33(1):75–76.

Mao XM, Zhang JQ, Zhou YP. Effect of silymarin and quercetin on diabetic rats’ sciatic nerve, lens and RBC sorbitol content. J Chin Endocrinol Metab 1994; 10: 44 -45.

Liu CS, Dong YH, Feng LN, et al. Observation on Chinese drugs baicalin and berberin in treating diabetic rats aldose reductase activity. J Chin Diabet Mell 1996; 4(3):163–166.

Xu BZ, Liu FP, Wang HT, et al. Effect of Atriplicis sibiricae on conduction velocity of mice tail nerve and sciatica nerve sorbitol content. CJIM 1996; 16(Sullp): 102 -104.

Xiong MQ, Tang CP, Zheng GF. Change of ultrastructure and sciatica nerve sorbital passage of diabetic rats and effect of Qitao tablet on its results. CJIM 1996; 16 (Sullp): 104–106.

Kinoshita JH. A thirty year journey in polyol pathway. Exp Eye Res 1990; 50:567–573.

Hasegawa G, Yoshinobu T, Shinichiro A. et al. Relationship between erythrocyte sorbitol content and diabetic microangiopathy in NIDDM: the study of a diet loading test. Diabetes Res Clin Practice 1991; 12(3): 143–148.

Zhang JQ, Mao XM. Zhou YP. Effect of silymarin on RBC sorbitol content and periphery nerve conduction velocity of II type diabetic patients. CJIM 1993;13(12): 725 -726.

Malone JI, Peterson MM. Red blood cell sorbitol as an indicator of polyol pathway activity inhibition by sorbinil in IDDM. Diabetes 1984;33:45–49.

Jaspan JB, Maselli R, Herold K, et al. Treatment of severely painful diabetic neuropathy with an aldose reductase inhibitor; relief of pain and improved somatic and autonomic nerve function. Lancet 1983; 2:758–762.

Judzewitsch RG, Jonathan MBBS, Jaspan B, et al. Aldose reductase inhibitor improves nerve conduction velocity in diabetic patients. N Engl J Med 1983;308:119–125.

Sima AAF, Bril V, Nathaniel V, et al. Regeneration and repair of myelinated fibers in sural nerve biopsy specimens from patients with diabetic neuropathy treated with sorbinil. N Engl J Med 1988; 319:548–555.

O Hare JP, Morgan MH, Alden P, et al. Aldose reductase inhibition in diabetic neuropathy: clinical and neurophysio- logical studies of one year’s treatment with sorbinil. Diabet Med 1988;5:537–542.

Boulton AJM. The effect and safety of the aldose reductase inhibitor tolrestat in the treatment of chronic sensorimotor diabetic neuropathy. Diabetologia 1989;32:469A.

Greene DA, Bochenek W. Harati Y, et al. Biochemical and morphometic response to tolrestat in human diabetic nerve. Diabetologia 1990;33:92A.

Gonen B, Bochenek W, Beg M, et al. The effect of withdrawal of tolrestat, aldose reductase inhititor, on signs, symptoms and nerve function in diabetic neuropathy. Diabetologia 1991;34(Suppl 2): 135A.

Toda Kenji. Treating the impairment of peripheral nerve of diabetes mellitus with modern Chinese recipes. Diagnosis and Treatment 1987; 74:2330.

Ghahary A. Increased renal aldose reductase activity, immunoreactivity, and mRNA in streptozocin-induced diabetic rats. Diabetes 1989;38:1067–1070.

FULL TEXT LINK

More>

浏览量

362

Downloads

CSCD

文章被引用时，请邮件提醒。

Submit

工具集

关联资源

Baicalin attenuates focal cerebral ischemic reperfusion injury by inhibition of protease-activated receptor-1 and apoptosis

Immune reconstitution—the footing of chinese medicine treatment for acquired immunodeficiency syndrome

Nerve regeneration should be highly valued in the treatment of diabetic peripheral neuropathy

Strategies and methods for the treatment of diabetic neuropathy using integrative Chinese and Western medicine

The prevention and treatment of restenosis in the era of drug-eluting stent